Bank of New York Mellon
BIOA

Bank of New York Mellon’s BioAmber Inc. BIOA Stock Holding History

Bank of New York Mellon’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,405
Closed -$5K – 4489
2017
Q4 		$5K Sell
12,405
-41,701
-77% -$19.8K ﹤0.01% 4346
2017
Q3 		$27K Hold
54,106
– – ﹤0.01% 4191
2017
Q2 		$139K Buy
54,106
+41,701
+336% +$95.8K ﹤0.01% 3968
2017
Q1 		$29K Sell
12,405
-9,556
-44% -$36.3K ﹤0.01% 4199
2016
Q4 		$121K Buy
21,961
+8,805
+67% +$42.2K ﹤0.01% 3994
2016
Q3 		$56K Sell
13,156
-2,155
-14% -$7.96K ﹤0.01% 4129
2016
Q2 		$46K Hold
15,311
– – ﹤0.01% 4187
2016
Q1 		$64K Hold
15,311
– – ﹤0.01% 4047
2015
Q4 		$95K Hold
15,311
– – ﹤0.01% 4078
2015
Q3 		$82K Hold
15,311
– – ﹤0.01% 4157
2015
Q2 		$132K Buy
15,311
+793
+5% +$7.25K ﹤0.01% 3989
2015
Q1 		$126K Hold
14,518
– – ﹤0.01% 3999
2014
Q4 		$122K Hold
14,518
– – ﹤0.01% 3997
2014
Q3 		$145K Buy
+14,518
New +$170K ﹤0.01% 3964

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bank of New York Mellon's BIOA Position: Q1 2018 in Review

Bank of New York Mellon sold out of BioAmber Inc. (BIOA) in Q1 2018, closing a stake of 12,405 shares — an estimated $5K sold.

Bank of New York Mellon first reported a position in BIOA in Q3 2014 and held it in 14 quarters. The position peaked at $145K in Q3 2014. 4 funds tracked by Wall St. Rank hold BIOA as of Q1 2018.

  • Bank of New York Mellon reported no remaining BioAmber Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 12,405 BioAmber Inc. shares in Q1 2018, an estimated $5K.
  • Bank of New York Mellon first reported a position in BioAmber Inc. in Q3 2014 and held it in 14 quarters.
  • Bank of New York Mellon's BioAmber Inc. position peaked at $145K in Q3 2014.
  • 4 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.